|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT01165697 |
|
Date of registration:
|
16/07/2010 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Establishment of Biomarkers for Fabry Disease
|
|
Scientific title:
|
Establishment of Biomarkers for Fabry Disease |
|
Date of first enrolment:
|
July 2010 |
|
Target sample size:
|
4 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT01165697 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Deborah M Grzybowski, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Ohio State University |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Fabry patient
- evidence of angiopathy (renal, cardiac, or ocular)
- Patients above the age of 18
Exclusion Criteria:
- Patients unable or unwilling to provide written informed consent will not be recruited
- Patients who are below the age of 18
- Patients who have not or will not be undergoing Fluorescein angiography
- Allergy to fluorescein
- Pregnant women and fetuses are exclude from the study due to risks related to
fluorescein and no direct benefit to the pregnant woman and fetus
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Fabry Disease
|
|
Intervention(s)
|
|
Other: Fluorescein angiography
|
|
Primary Outcome(s)
|
|
Presence of specific findings commonly associated with Fabry's disease using neuroretinal examination
[Time Frame: every 6 months, for up to 3 years]
|
|
Secondary Outcome(s)
|
|
Capillary perfusion abnormalities in optic nerve and retina
[Time Frame: every 6 months, for up to 3 years]
|
|
Secondary ID(s)
|
|
2009H0137
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|